INTERNATIONAL PATENT: THIOGENESIS THERAPEUTICS, INC. FILES APPLICATION FOR "PHARMACEUTICALLY ACCEPTABLE SALTS OF CYSTEAMINE-PANTETHEINE DISULFIDE AND USES THEREOF"

GENEVA, Sept. 22 -- THIOGENESIS THERAPEUTICS, INC. (4795 Keswick CourtSan Diego, CA 92130) filed a patent application (PCT/US2025/019991) for "PHARMACEUTICALLY ACCEPTABLE SALTS OF CYSTEAMINE-PANTETHEINE DISULFIDE AND USES THEREOF" on Mar 14, 2025. With publication no. WO/2025/194075, the details related to the patent application was published on Sep 18, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): POWELL, Kathlene (123 Emerald Creek DriveTroutman, NC 28166), RIOUX, Patrice P. (4795 Keswick CourtSan Diego, CA 92130), WANG, Xiaoyang (90 Delin RoadWaigaoqiao Free Trade ZoneShanghai, 200131),...